Rhumbline Advisers Has $5.06 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Rhumbline Advisers trimmed its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 0.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,775 shares of the company’s stock after selling 209 shares during the period. Rhumbline Advisers owned about 0.36% of U.S. Physical Therapy worth $5,062,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Natixis Advisors LLC raised its stake in U.S. Physical Therapy by 4.9% in the second quarter. Natixis Advisors LLC now owns 23,553 shares of the company’s stock valued at $2,177,000 after buying an additional 1,098 shares during the period. Peregrine Capital Management LLC increased its holdings in shares of U.S. Physical Therapy by 1.3% during the 2nd quarter. Peregrine Capital Management LLC now owns 96,334 shares of the company’s stock worth $8,903,000 after acquiring an additional 1,253 shares during the last quarter. Innealta Capital LLC bought a new stake in U.S. Physical Therapy in the 2nd quarter valued at $30,000. Ridgewood Investments LLC acquired a new stake in U.S. Physical Therapy during the 2nd quarter valued at $51,000. Finally, Bank of New York Mellon Corp boosted its position in U.S. Physical Therapy by 3.4% during the second quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock worth $14,515,000 after purchasing an additional 5,111 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares of the company’s stock, valued at $580,635. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

USPH has been the topic of several research analyst reports. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Barrington Research lowered their price target on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating on the stock in a report on Thursday, August 15th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus target price of $112.50.

U.S. Physical Therapy Stock Up 2.1 %

USPH opened at $84.59 on Monday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The stock has a fifty day moving average of $89.41 and a 200-day moving average of $97.72. U.S. Physical Therapy, Inc. has a fifty-two week low of $78.08 and a fifty-two week high of $113.63. The company has a market capitalization of $1.28 billion, a P/E ratio of 68.77, a P/E/G ratio of 4.06 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The business had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same period in the prior year, the firm earned $0.76 EPS. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were paid a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.08%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.